Molecules 2020, 25, 1051
9 of 14
with 5-membered-ring hemiacetal 2,4-DHHDP: 94.3 (glc-1), 74.2 (glc-2), 67.5 (glc-3), 69.6 (glc-4), 77.1
(glc-5), 68.0 (glc-6); glucose with 6-membered-ring hemiacetal 2,4-DHHDP: 95.4 (glc-1), 73.6 (glc-2),
69.0 (glc-3), 68.7 (glc-4), 76.5 (glc-5), 67.9 (glc-6).
3.5. Preparation of Acetonyl Derivative
Amariin (1) (130 mg) was dissolved in 80% acetone (20 mL) containing HCO2NH4 (130 mg) and
stirred at r.t. for 13h. After removal of acetone by evaporation, the aqueous solution was subjected to
Diaion HP20SS column chromatography (2 cm i.d. × 15 cm, 0%–60% MeOH in H2O, 5% stepwise,
each 50 mL) to yield 1a (57.2 mg).
Bisacetonyl derivative (1a): off-white amorphous powder, [α]1D7 −55.2 (c 0.1, MeOH); IRνmax cm : 3406,
−1
1
1715, 1620, 1531, 1441; UV (MeOH) λmax (log ε): 282 (4.56), 221 (4.91). H NMR (500 MHz, acetone-d6)
1
δ: H-NMR (acetone-d6, 500 MHz) δ: 2.19 (3H, s, 2,4-acyl-CH3), 2.23 (3H, s, 3,6-acyl-CH3), 2.96 (1H, d,
J = 15.3 Hz, 3,6-acyl-CH2), 3.06 (1H, d, J = 15.6 Hz, 2,4-acyl-CH2), 3.46 (1H, d, J = 15.6 Hz, 2,4-acyl-CH2),
3.48 (1H, d, J = 15.3 Hz, 3,6-acyl-CH2), 4.21 (1H, dd, J = 1.2, 13.1 Hz, glc-6a), 4.83 (1H, d, J = 1.5 Hz, 3,6-
acyl-1), 4.88 (1H, br. s, glc-5), 4.98 (1H, d, J = 1.5 Hz, 2,4-acyl-1’), 5.39 (1H, dt, J = 1.4, 3.8 Hz, glc-4),
5.47 (1H, dt, J = 1.5, 4.9 Hz, glc-2), 5.57 (1H, dd, J = 3.2, 13.1 Hz, glc-6b), 5.70 (1H, dd, J = 1.4, 3.8 Hz,
glc-3), 6.35 (1H, d, J = 1.5 Hz, 2,4-acyl-3’), 6.44 (1H, d, J = 4.9 Hz, glc-1), 6.46 (1H, d, J = 1.5 Hz, 3,6-acyl-
13
3), 7.20 (1H, s, 3,6-acyl-3’), 7.22 (1H, s, 2,4-acyl-3), 7.27 (2H, s, galloyl-H); C NMR (acetone-d6, 125
MHz) δ: 32.0 (2,4-acyl-CH3), 32.2 (3,6-acyl-CH3), 49.2 (3,6-acyl-CH2), 49.9 (2,4-acyl-CH2), 50.8 (3,6-acyl-
1), 51.9 (2,4-acyl-1’), 64.5 (glc-6), 66.0 (glc-3), 69.7 (glc-4), 73.8 (glc-2), 78.1 (glc-5), 80.2 (3,6-acyl-5), 80.6
(2,4-acyl-5’), 94.3 (glc-1), 110.0 (2,4-acyl-6’), 110.4 (galloyl-2, 6), 110.6 (3,6-acyl-6), 113.0 (2,4-acyl-3, 3,6-
acyl-3’), 116.9 (2,4-acyl-1), 117.9 (3,6-acyl-1’), 119.9 (3,6-acyl-2’), 120.1 (galloyl-1), 120.5 (2,4-acyl-2),
127.1 (3,6-acyl-3), 127.5 (2,4-acyl-3’), 136.5 (3,6-acyl-5’), 137.3 (2,4-acyl-5), 139.6 (galloyl-4), 144.6 (3,6-
acyl-2), 144.9 (2,4-acyl-2’), 146.1 (galloyl-3, 5), 146.7 (3,6-acyl-6’), 147.0 (2,4-acyl-6), 147.4 (2,4-acyl-4,
3,6-acyl-4’), 164.3 (2,4-acyl-7), 164.9 (galloyl-7, 3,6-acyl-7), 166.1 (2,4-acyl-7’), 166.9 (3,6-acyl-7’), 196.9
(3,6-acyl-4), 197.2 (2,4-acyl-4’), 205.7 (2,4-acyl-CO), 205.9 (3,6-acyl-CO).
3.6. Preparation of Phenazine Derivative
Amariin (1) (50 mg) and O-phenylenediamine (10 mg) was dissolved in 10% AcOH in EtOH (2
mL) and heated at 50˚C for 2 h. The mixture was applied to Sephadex LH-20 (2 cm i.d. × 15 cm, 0-20%
H2O in EtOH, 10% stepwise, each 100 mL) to yield 1b (30.2 mg). Phenazine derivative 3a was
prepared from 3 in the same way.
Phenazinde derivative (1b): UV (MeOH) λmax (log ε) 445 (3.56), 378 (4.13), 281 (4.98), 205 (4.87); ECD
1
(MeOH) Δε (nm) 377 (−1.48), 325 (+3.86), 284 (−67.5), 250 (+72.1), 221 (−42.0). H NMR (acetone-d6, 500
MHz) δ: 4.11 (1H, dd, J = 3.3, 12.0 Hz, glc-6a), 4.98 (1H, dd, J = 8.1, 12.0, glc-6b), 5.04 (1H, dd, J = 3.3,
8.1, glc-5), 5.40 (1H, d, J = 4.1, glc-4), 5.80 (1H, d, J = 4.1, glc-3), 5.86 (1H, d, J = 5.5, glc-2), 6.23 (1H, d, J
= 5.5, glc-1), 7.01 (2H, s, galloyl-H), 7.03 (1H, s, 3,6-acyl-3’), 7.52 (1H, s, 2,4-acyl-3), 8.24 (1H, s, 3,6-acyl-
13
3), 8.31 (1H, s, 2,4-acyl-3’); C-NMR (acetone-d6, 125 MHz) δ: 64.7 (glc-6), 67.7 (glc-3), 68.3 (glc-4), 76.2
(glc-2), 77.0 (glc-5), 91.7 (glc-1), 109.7 (2,4-acyl-3), 110.1 (galloyl-2, 6), 113.2 (3,6-acyl-3’), 115.2 (3,6-
acyl-1’), 116.4 (2,4-acyl-1), 116.7 (3,6-acyl-1), 116.8 (2,4-acyl-1’), 119.8 (galloyl-1), 120.1 (2,4-acyl-3’),
120.6 (2,4-acyl-2), 120.7 (3,6-acyl-3), 123.1 (3,6-acyl-2’), 130.0, 130.4, 130.5 (2,4-acyl-4”, 5”, 3,6-acyl-4”,
5”), 132.2, 132.3 (2,4-acyl-3”, 6”, 3,6-acyl-3”, 6”), 136.0 (2,4-acyl-2’), 136.3 (3,6-acyl-2), 137.4 (3.6-acyl-
5’), 138.0, 139.0 (2,4-acyl-5’, 3,6-acyl-5), 139.3 (2,4-acyl-5), 139.6 (galloyl-4), 142.8, 143.0, 143.1, 145.1,
145.3, 145.4, 145.6, 145.9 (2,4-acyl-6, 4’, 1”, 2”, 3,6-acyl-4, 4’, 6’, 1”, 2”), 145.3 (2,4-acyl-4), 146.0 (galloyl-
3, 5), 152.1 (3,6-acyl-6), 152.3 (2,4-acyl-6’), 164.7 (galloyl-7), 165.9 (3,6-acyl-7), 166.6 (2,4-acyl-7’), 167.8
(3,6-acyl-7’), 167.9 (2,4-acyl-7).
Phenazine derivative (3a): Brown amorphous powder, [α]1D7 −323.9 (c 0.06, MeOH); FAB-MS m/z: 1077
+
+
+
[M + H] , 1099 [M + Na] ; HR-FAB-MS m/z: 1099.1403 [M + Na] , (calcd. for C53H32O22N4Na, 1099.1406);
−1
IR vmax cm : 3336, 1732, 1613, 1509, 1463, 1355, 1335, 1308, 1189; UV (MeOH) λmax (log ε): 446 sh (3.51),
375 (4.15), 279 (5.00), 223 sh (4.86), 207 (4.89); ECD (MeOH) λmax (Δε): 381 (+3.8), 359 (+1.3), 304 (+16.9),